Zhandos Burkitabayev

Zhandos Burkitabayev

Auto-generated profile, based on publicly available information

Zhandos Burkitabayev

National Research Oncology Center, Astana, Kazakhstan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2026 in Electronic Journal of General Medicine
Verified
Journal Article
Open access
PDF file
ZBZhandos Burkitbayev
Zhandos Burkitbayev
RARuslan Akhmedullin
Ruslan Akhmedullin
DZDinara Zharlyganova
Dinara Zharlyganova
AMAlmira Manatova
Almira Manatova
ZKZhuldyz Kuanysh
Zhuldyz Kuanysh
AGAbduzhappar Gaipov
Abduzhappar Gaipov
Background: Central Asia is known to face various ecological challenges that constitute major risk factors for cancer. This study explored the cancer burden in Central Asia, where the estimates are among the highest worldwide. Methods: Extracting data from the latest global burden of disease study (GBD 2021), the authors investigated the disability-adjusted life years (DALYs), deaths, and incidence of various cancer groups in Central Asian countries from to 1990-2021. We conducted descriptive analyses of cancer statistics and calculated the average annual percent change (AAPC) to analyze the temporal patterns for individual country estimates. Results: Over the study period, DALYs decreased and were primarily driven by premature deaths, with pronounced estimates in male subjects. While DALYs, deaths, and incidence figures were somewhat comparable for most countries, Kazakhstan had exceptionally high estimates during the 1990s. However, over the following decades, the country revealed the highest decrease for all the metrics, measured by the AAPCs for incidence -1.32% (95% uncertainty interval [UI]: -1.44% to -1.19%); deaths -2.28% (95% UI: -2.51% to -2.05%); DALYs -2.50% (95% UI: -2.74% to -2.24%). Across the region, the leading cancer sites were tracheal, bronchus, and lung, stomach, colon and rectum and esophageal cancers, in both sexes combined. Sex-specific cancer estimates showed slight variations, with a notable burden observed in females. Conclusion: This study revealed an overall decrease in the cancer burden between 1990 and 2021. However, the temporal patterns of the risk factors remain a concern. Our findings highlight the importance of preventive measures and early diagnosis. Additionally, when interpreting GBD 2021 findings, future studies should consider the potential impact of salmon bias, where selective migration affects the modelled estimates.

17 April 2021 in Journal of Clinical Medicine of Kazakhstan
Verified
Journal Article
Open access
PDF file
JSJamilya Saparbay
Jamilya Saparbay
VKVadim Kemaykin
Vadim Kemaykin
RVRuzal Vildanova
Ruzal Vildanova
AKAzat Karabekov
Azat Karabekov
ZBZhandos Burkitabayev
Zhandos Burkitabayev
Introduction: The COVID-19 pandemic is a problem of a global scale, and it has an importance in modern oncology and hematology. Patients with cancer are at high risk of getting infected with COVID-19. Diagnosis of coronavirus infection in such patients entails the cancellation of chemotherapy for an indefinite period. A break between courses of treatment, as well as a complete cancellation of therapy, can increase the mortality of patients from oncohematological diseases. Material and methods: From June to October 2020, based on the Oncohematological Department of the National Research Oncology Center LLP, 19 patients were treated, of which: men - 11, women - 8. Average age - 43 years (+ -16). Of these, patients with multiple myeloma - 32%; acute myeloid leukemia - 26%; acute promyelocytic leukemia - 11%; acute lymphoblastic leukemia - 26%; chronic lymphocytic leukemia - 5%. Treatment was carried out following the protocols for the diagnosis and treatment of hemoblastosis and concomitant COVID-19 infection. Results: This article presents clinical cases of complex therapy of patients with hemoblastosis and concomitant COVID-19 infection who were treated in a hospital.